PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SDGR vs. VKTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SDGR and VKTX is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

SDGR vs. VKTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Schrodinger, Inc. (SDGR) and Viking Therapeutics, Inc. (VKTX). The values are adjusted to include any dividend payments, if applicable.

-60.00%-40.00%-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2025February
13.94%
-47.28%
SDGR
VKTX

Key characteristics

Sharpe Ratio

SDGR:

-0.44

VKTX:

-0.03

Sortino Ratio

SDGR:

-0.30

VKTX:

1.23

Omega Ratio

SDGR:

0.97

VKTX:

1.15

Calmar Ratio

SDGR:

-0.32

VKTX:

-0.07

Martin Ratio

SDGR:

-0.77

VKTX:

-0.11

Ulcer Index

SDGR:

34.91%

VKTX:

40.75%

Daily Std Dev

SDGR:

61.13%

VKTX:

149.01%

Max Drawdown

SDGR:

-85.64%

VKTX:

-90.41%

Current Drawdown

SDGR:

-79.98%

VKTX:

-63.95%

Fundamentals

Market Cap

SDGR:

$1.65B

VKTX:

$3.80B

EPS

SDGR:

-$2.45

VKTX:

-$1.01

Total Revenue (TTM)

SDGR:

$119.22M

VKTX:

$0.00

Gross Profit (TTM)

SDGR:

$67.95M

VKTX:

-$236.00K

EBITDA (TTM)

SDGR:

-$184.19M

VKTX:

-$104.61M

Returns By Period

In the year-to-date period, SDGR achieves a 17.37% return, which is significantly higher than VKTX's -15.33% return.


SDGR

YTD

17.37%

1M

-7.25%

6M

13.94%

1Y

-25.72%

5Y*

-15.69%

10Y*

N/A

VKTX

YTD

-15.33%

1M

-2.49%

6M

-47.28%

1Y

-8.95%

5Y*

38.05%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SDGR vs. VKTX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SDGR
The Risk-Adjusted Performance Rank of SDGR is 2727
Overall Rank
The Sharpe Ratio Rank of SDGR is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of SDGR is 2626
Sortino Ratio Rank
The Omega Ratio Rank of SDGR is 2626
Omega Ratio Rank
The Calmar Ratio Rank of SDGR is 2727
Calmar Ratio Rank
The Martin Ratio Rank of SDGR is 3131
Martin Ratio Rank

VKTX
The Risk-Adjusted Performance Rank of VKTX is 5252
Overall Rank
The Sharpe Ratio Rank of VKTX is 4545
Sharpe Ratio Rank
The Sortino Ratio Rank of VKTX is 6565
Sortino Ratio Rank
The Omega Ratio Rank of VKTX is 6363
Omega Ratio Rank
The Calmar Ratio Rank of VKTX is 4242
Calmar Ratio Rank
The Martin Ratio Rank of VKTX is 4444
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SDGR vs. VKTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Schrodinger, Inc. (SDGR) and Viking Therapeutics, Inc. (VKTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SDGR, currently valued at -0.44, compared to the broader market-2.000.002.00-0.44-0.03
The chart of Sortino ratio for SDGR, currently valued at -0.29, compared to the broader market-4.00-2.000.002.004.006.00-0.301.23
The chart of Omega ratio for SDGR, currently valued at 0.97, compared to the broader market0.501.001.502.000.971.15
The chart of Calmar ratio for SDGR, currently valued at -0.32, compared to the broader market0.002.004.006.00-0.32-0.07
The chart of Martin ratio for SDGR, currently valued at -0.77, compared to the broader market-10.000.0010.0020.0030.00-0.77-0.11
SDGR
VKTX

The current SDGR Sharpe Ratio is -0.44, which is lower than the VKTX Sharpe Ratio of -0.03. The chart below compares the historical Sharpe Ratios of SDGR and VKTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00SeptemberOctoberNovemberDecember2025February
-0.44
-0.03
SDGR
VKTX

Dividends

SDGR vs. VKTX - Dividend Comparison

Neither SDGR nor VKTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SDGR vs. VKTX - Drawdown Comparison

The maximum SDGR drawdown since its inception was -85.64%, smaller than the maximum VKTX drawdown of -90.41%. Use the drawdown chart below to compare losses from any high point for SDGR and VKTX. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%SeptemberOctoberNovemberDecember2025February
-79.98%
-63.95%
SDGR
VKTX

Volatility

SDGR vs. VKTX - Volatility Comparison

The current volatility for Schrodinger, Inc. (SDGR) is 15.30%, while Viking Therapeutics, Inc. (VKTX) has a volatility of 19.76%. This indicates that SDGR experiences smaller price fluctuations and is considered to be less risky than VKTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February
15.30%
19.76%
SDGR
VKTX

Financials

SDGR vs. VKTX - Financials Comparison

This section allows you to compare key financial metrics between Schrodinger, Inc. and Viking Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab